Related Experiment Videos
Sick-day management in type 1 diabetes
1Pediatric and Adolescent Unit, Joslin Clinic, Joslin Diabetes Center, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. lori.laffel@joslin.harvard.edu
Endocrinology and Metabolism Clinics of North America
|January 10, 2001
Summary
Managing type 1 diabetes during illness requires attention to blood glucose and ketone monitoring. New blood 3-hydroxybutyrate (3HB) tests offer a potentially better alternative to urine ketone testing for sick-day management.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Illness and stress can trigger metabolic deterioration in type 1 diabetes.
- Effective sick-day management, including ketone monitoring, is crucial to prevent complications.
- Traditional urine ketone testing has limitations.
Purpose of the Study:
- To evaluate new blood 3-hydroxybutyrate (3HB) self-monitoring technology for sick-day management in type 1 diabetes.
- To compare blood 3HB monitoring with traditional urine ketone testing.
Main Methods:
- Review of current sick-day management practices for type 1 diabetes.
- Introduction of new blood 3HB self-monitoring technology.
- Discussion of American Diabetes Association recommendations on blood 3HB testing.
Main Results:
- Blood 3HB monitoring may provide a useful alternative to urine ketone testing.
- New technology offers an opportunity to improve sick-day management.
Conclusions:
- Improved sick-day management can reduce the burden of diabetic ketoacidosis (DKA).
- Blood 3HB monitoring represents a potential advancement in diabetes care, especially during illness.